Ropes & Gray represented GHO Capital Partners and Ampersand Capital Partners in the transaction, and Cooley represented Avid Bioservices, Inc. GHO Capital Partners, LP (“GHO Capital”),...
GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices
Becton, Dickinson and Company’s Acquisition of Critical Care Product Group of Edwards Lifesciences
Skadden is advising Edwards Lifesciences, while Ropes & Gray is providing legal counsel to BD on the deal. Edwards Lifesciences has entered into a definitive agreement...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
GHO Capital and The Vistria Group’s Acquisition of Alcami
Ropes & Gray represented GHO Capital and The Vistria Group, while Kirkland & Ellis represented Alcami in the transaction. GHO Capital and The Vistria Group announced...
RoslinCT’s Merger with Lykan Bioscience
Ropes & Gray and Slaughter & May acted as legal advisors to GHO, while McDermott Will & Emery LLP advised WindRose Health Investors, LLC. RoslinCT entered into...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
The Vistria Group’s Acquisition of BioCare
Ropes & Gray represented The Vistria Group on the transaction. The Vistria Group executed its acquisition of BioCare, Inc. Terms of the transaction were not disclosed. BioCare...